BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16818761)

  • 1. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
    Engelhardt JJ; Sullivan TJ; Allison JP
    J Immunol; 2006 Jul; 177(2):1052-61. PubMed ID: 16818761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.
    Buhlmann JE; Elkin SK; Sharpe AH
    J Immunol; 2003 Jun; 170(11):5421-8. PubMed ID: 12759417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
    Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
    J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
    Li D; Gál I; Vermes C; Alegre ML; Chong AS; Chen L; Shao Q; Adarichev V; Xu X; Koreny T; Mikecz K; Finnegan A; Glant TT; Zhang J
    J Immunol; 2004 Dec; 173(12):7135-9. PubMed ID: 15585834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
    Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
    J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
    Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
    J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
    Kwon H; Jun HS; Khil LY; Yoon JW
    J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
    Yi LA; Hajialiasgar S; Chuang E
    Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF; Allison JP
    J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.
    Hwang KW; Sweatt WB; Mashayekhi M; Palucki DA; Sattar H; Chuang E; Alegre ML
    J Immunol; 2004 Nov; 173(9):5415-24. PubMed ID: 15494488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.
    Tang Q; Henriksen KJ; Boden EK; Tooley AJ; Ye J; Subudhi SK; Zheng XX; Strom TB; Bluestone JA
    J Immunol; 2003 Oct; 171(7):3348-52. PubMed ID: 14500627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 17. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
    Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.
    Walker LS; Wiggett HE; Gaspal FM; Raykundalia CR; Goodall MD; Toellner KM; Lane PJ
    J Immunol; 2003 Jan; 170(1):91-8. PubMed ID: 12496387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.